Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma-Reference-Cited by-同舟云学术

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma

Published:2018-04-17 Issue:29 Volume:9 Page:20563-20577
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lamanuzzi Aurelia¹,Saltarella Ilaria¹,Desantis Vanessa¹,Frassanito Maria Antonia²,Leone Patrizia¹,Racanelli Vito¹,Nico Beatrice³,Ribatti Domenico³⁴,Ditonno Paolo⁵,Prete Marcella¹,Solimando Antonio Giovanni¹,Dammacco Francesco¹,Vacca Angelo¹,Ria Roberto¹

Affiliation:

1. Department of Biomedical Sciences and Human Oncology, Internal Medicine Unit G. Baccelli, University of Bari Aldo Moro Medical School, Bari, Italy

2. Department of Biomedical Sciences and Human Oncology, General Pathology Unit, University of Bari Aldo Moro Medical School, Bari, Italy

3. Department of Basic Medical Sciences, Neurosciences, and Sensory Organs, Section of Human Anatomy and Histology, University of Bari Aldo Moro Medical School, Bari, Italy

4. National Cancer Institute Giovanni Paolo II, Bari, Italy

5. Hematology Unit, Di Venere Hospital, Bari, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets;Pathology - Research and Practice;2024-08

2. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer;Frontiers in Oncology;2024-07-17

3. Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications;Medical Oncology;2024-06-20

4. Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy;Cell Communication and Signaling;2024-06-11

5. Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma;Biomedicines;2024-02-24